Hema Padmanabhan, MD
Disclosures: The author has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L19-0319.
Padmanabhan H. Fracture Risk After Initiation of Use of Canagliflozin. Ann Intern Med. 2019;171:79–80. doi: https://doi.org/10.7326/L19-0319
Download citation file:
© 2019
Published: Ann Intern Med. 2019;171(1):79-80.
DOI: 10.7326/L19-0319